Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2003
12/11/2003WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments
12/11/2003US20030229231 Forming chelate compounds
12/11/2003US20030229121 Antihistamines, antiallergens, skin disorders, antiinflammatory agents
12/11/2003US20030229116 Enamine derivatives
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229106 Antihistamines, diarrhea
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
12/11/2003US20030229075 Induce immunology response; genetic engineering; gene expression; crystallization
12/11/2003US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229064 Method of treating cancer using dithiocarbamate derivatives
12/11/2003US20030229045 CFTR gene regulator
12/11/2003US20030228359 Antiallergen mixture
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003CA2487905A1 Use of cgmp - stimulating compounds
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487679A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003CA2487675A1 Novel substituted indoles
12/11/2003CA2487509A1 New salts
12/11/2003CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives
12/10/2003EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors
12/10/2003EP1369409A1 Process for preparing compounds useful as intermediates
12/10/2003EP1369127A1 Novel medicinal use of aplpha antigen or alpha antigen gene
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368366A1 Non-natural nucleotides and dinucleotides
12/10/2003EP1368356A2 N-but-3-enyl norbuprenorphine and its use as analgesic
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368313A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368253A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
12/10/2003EP1368063A2 Complex of modafinil and cyclodextrin
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1368027A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
12/10/2003EP1368005A2 Chronotherapeutic dosage forms
12/10/2003EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367980A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/10/2003EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
12/10/2003EP1123936B1 Fused pyridazine derivatives, process for the preparation of the same and uses thereof
12/10/2003EP0853615B1 Piperidine compounds as calcium channel blockers
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003CN1461338A Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1461216A Compound for use as medicament for treatment of disorders involving bronchocontraction
12/10/2003CN1461211A Microparticles for pulmonary administation
12/10/2003CN1460514A Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS
12/10/2003CN1460505A Argyi leaf oil soft capsule and its production method
12/10/2003CN1460502A Chinese medicine for curing sore-throat
12/10/2003CN1460492A Chinese medicine preparation for curing acute and chronic rhinitis and its production method
12/10/2003CN1460490A Chinese medicine powder inhalant for curing asthma, its preparation method and application
12/10/2003CN1460487A Propolis soft capsule and its preparation method
12/10/2003CN1460474A Application of geldanamycin in preparation of medicine for curing SARS
12/10/2003CN1130374C Synthetic peptide analogs of lung surfactant protein SP-C
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/10/2003CN1130202C Compound nose drops and its preparation method
12/09/2003US6660746 Cardiovascular disorders
12/09/2003US6660745 Phosphodiesterase inhibitors; treatment of asthma, chronic obstructive pulmonary disease, inflammatory disorders
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660715 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
12/09/2003US6660261 Bordetella strain expressing the FHA hybrid, liposomes and vaccines
12/09/2003US6660249 Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infections
12/09/2003CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
12/09/2003CA2140247C Novel vitamin d analogues
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099807A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
1 ... 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 ... 878